Suven Life Sciences Limited (BOM:530239)
India · Delayed Price · Currency is INR 267.85
-10.60 (-3.81%)
At close: Oct 22, 2026
Suven Life Sciences Employees
Suven Life Sciences had 142 employees as of March 31, 2026. The number of employees increased by 4 or 2.90% compared to the previous year. That makes Suven Life Sciences the 29,277th largest employer in the world and 2,684th in India.
Employees
142
Change (1Y)
4
Growth (1Y)
2.90%
Revenue / Employee
620.69K INR
Profits / Employee
-24.82M INR
Market Cap
75.68B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 142 | 4 | 2.90% |
| Mar 31, 2025 | 138 | -3 | -2.13% |
| Mar 31, 2024 | 141 | 10 | 7.63% |
| Mar 31, 2023 | 131 | 14 | 11.97% |
| Mar 31, 2022 | 117 | -13 | -10.00% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IOL Chemicals and Pharmaceuticals | 3,095 |
| Neuland Laboratories | 2,183 |
| Symbiotec Pharmalab | 1,915 |
| Shilpa Medicare | 1,241 |
| Bajaj HealthCare | 949 |
| NGL Fine-Chem | 498 |
| Influx Healthtech | 278 |
| Shree Ganesh Remedies | 224 |
Suven Life Sciences News
- 3 months ago - Suven Life Sciences allots 1.85 crore shares on preferential basis for Rs 248.84 crore - Business Upturn
- 3 months ago - Suven Life Sciences raises ₹248.84 crore through preferential allotment - Business Upturn
- 4 months ago - Suven Life Sciences to showcase CNS clinical candidates at BIO-2026 in San Diego - Business Upturn
- 4 months ago - Suven Life Sciences reports positive results from Ropanicant Phase-2b trial for depression - Business Upturn
- 4 months ago - Suven Life Sciences successfully completes Phase-1 Clinical Trial of SUVN-I6107 for CNS disorders - Business Upturn
- 4 months ago - Suven Life Sciences to present Phase-3 narcolepsy study at SLEEP-2026 - Business Upturn
- 4 months ago - Suven Life Sciences reports positive DSMB review in Alzheimer's study - Business Upturn
- 5 months ago - Suven Life Sciences shares rally over 17% today; Details here - Business Upturn